4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017033
Chief Financial Officer acquired 45,258 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2021-03-01 | Grant or award | +45,258 | 175,804 | D | ||
| Derivatives | |||||||
| Koppikar Utpal Chief Financial Officer | 2021-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +68,314 | 68,314 | D | ||
Loading xslF345X03/doc4.xml…